Netflix (NFLX:NAS) and Interactive Brokers Group (IBKR:NAS) Are Fully Valued

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com



I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.

Fully Valued Stocks on NASDAQ

Today we are looking at companies that are considered fully valued based on the Analyst data in the StockCalc database.

In this table we can see the close price and target price for these companies along with the number of analysts covering the stock. We also have included the fiscal year for the target price as sometimes these analyst targets are not for the current or even the next fiscal year.

There can be a number of reasons why a company would be on this list. What is particularly interesting are companies with a large analyst following that make this list. We need to dig deeper into these companies to understand why the difference in price versus target.

Today’s Data on NASDAQ

Today’s data is for companies listed on the NASDAQ.

Symbol Name Target Year Close Price Target Price Mean Currency Target Price # of Estimates
NFLX Netflix Inc 2018 349.730000 324.0000 USD 11
IBKR Interactive Brokers Group Inc 2018 74.070000 65.0000 USD 1
ALGN Align Technology Inc 2018 326.180000 316.2500 USD 4
IDXX IDEXX Laboratories Inc 2018 205.250000 188.6667 USD 3
LULU Lululemon Athletica Inc 2019 105.680000 97.0000 USD 7
ANSS Ansys Inc 2018 161.590000 153.0000 USD 2
ODFL Old Dominion Freight Lines Inc 2018 154.700000 146.5000 USD 4
IEP Icahn Enterprises LP 2018 68.240000 49.0000 USD 1
FFIV F5 Networks Inc 2018 172.750000 158.5000 USD 4
MKTX MarketAxess Holdings Inc 2018 210.940000 190.0000 USD 1
CACC Credit Acceptance Corp 2018 349.450000 303.3333 USD 3
AZPN Aspen Technology Inc 2019 93.230000 84.0000 USD 1
UBNT Ubiquiti Networks Inc 2019 80.850000 66.5000 USD 2
LOXO Loxo Oncology Inc 2018 168.390000 122.0000 USD 1
HQY HealthEquity Inc 2019 76.760000 66.0000 USD 3
LGND Ligand Pharmaceuticals Inc 2018 187.060000 157.6667 USD 3
NEOG Neogen Corp 2019 73.890000 62.0000 USD 1
TTD The Trade Desk Inc 2018 82.730000 71.5000 USD 2
BCPC Balchem Corp 2018 97.120000 85.0000 USD 1
MNTA Momenta Pharmaceuticals Inc 2018 22.800000 10.0000 USD 1
NAVG Navigators Group Inc 2018 59.100000 45.0000 USD 1
ASTE Astec Industries Inc 2018 58.470000 50.0000 USD 1
SPSC SPS Commerce Inc 2018 74.410000 62.5000 USD 4
ATRI Atrion Corp 2018 583.450000 300.0000 USD 1
AMNB American National Bankshares Inc 2018 39.250000 10.0000 USD 1

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

NFLX:NAS Netflix

http://www.netflix.com
Netflix has 5500 employees and is headquartered in United States.
Netflix Inc provides multimedia content through the internet. It provides a subscription based platform for television shows, movies and original series.

IBKR:NAS Interactive Brokers Group

http://www.interactivebrokers.com
Interactive Brokers Group has 1252 employees and is headquartered in United States.
Interactive Brokers Group Inc is an automated electronic broker and market maker engaged in routing orders and executing and processing trades in securities, futures, foreign exchange instruments, and mutual funds.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.

Amazon.com (AMZN:NAS) and Alphabet (GOOGL:NAS) Are Undervalued

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com



I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.

Undervalued Stocks on NASDAQ

Today we are looking at companies that are considered undervalued based on the Analyst data in the StockCalc database.

In the table below we can see the close price and target price for these companies along with the number of analysts covering the stock. We also have included the fiscal year for the target price as sometimes these analyst targets are not for the current or even the next fiscal year.

There can be a number of reasons why a company would be on this list. What is particularly interesting are companies with a large analyst following that make this list. We need to dig deeper into these companies to understand why the difference in price versus target.

Today’s Data on NASDAQ

Today’s data is for companies listed on the NASDAQ.

Symbol Name Target Year Close Price Target Price Mean Currency Target Price # of Estimates
AMZN Amazon.com Inc 2018 1612.870000 1843.5450 USD 11
GOOG Alphabet Inc 2018 1060.320000 1251.8180 USD 11
GOOGL Alphabet Inc 2018 1068.070000 1251.8180 USD 11
AVGO Broadcom Inc 2018 249.690000 319.5454 USD 11
BKNG Booking Holdings Inc 2018 2076.030000 2338.3330 USD 6
CHTR Charter Communications Inc 2018 266.360000 409.5000 USD 4
BIIB Biogen Inc 2018 287.090000 340.8750 USD 8
CELG Celgene Corp 2018 77.830000 124.2857 USD 7
SHPG Shire PLC 2018 164.200000 216.3671 USD 4
LRCX Lam Research Corp 2019 200.280000 268.2857 USD 7
REGN Regeneron Pharmaceuticals Inc 2018 296.500000 393.6667 USD 6
EQIX Equinix Inc 2018 396.100000 515.0000 USD 5
MELI MercadoLibre Inc 2018 297.710000 380.0000 USD 1
SAGE Sage Therapeutics Inc 2018 151.820000 210.0000 USD 1
SINA SINA Corp 2018 89.990000 159.0000 USD 1
COHR Coherent Inc 2018 185.300000 246.0000 USD 3
TREE LendingTree Inc 2018 258.650000 324.8000 USD 5
ICPT Intercept Pharmaceuticals Inc 2018 70.750000 125.0000 USD 4
ANAB AnaptysBio Inc 2018 77.100000 135.0000 USD 1
AMWD American Woodmark Corp 2019 101.600000 156.0000 USD 1
MDGL Madrigal Pharmaceuticals Inc 2018 110.270000 173.2500 USD 4
OSTK Overstock.com Inc 2018 33.350000 100.0000 USD 1
VRTS Virtus Investment Partners Inc 2018 123.500000 173.0000 USD 1
ADMS Adamas Pharmaceuticals Inc 2018 28.220000 91.0000 USD 1
ALBO Albireo Pharma Inc 2018 32.050000 86.0000 USD 1

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

AMZN:NAS Amazon.com

http://www.amazon.com
Amazon.com has 566000 employees and is headquartered in United States.
Amazon.com Inc is an online retailer. The Company sells its products through the website which provides services, such as advertising services and co-branded credit card agreements. It also offers electronic devices like Kindle e-readers and Fire tablets.

GOOGL:NAS Alphabet

https://www.abc.xyz
Alphabet has 85050 employees and is headquartered in United States.
Alphabet Inc is a provider of internet content products and portals. Its suite of brands includes Search, Android, YouTube, Apps, Maps & Ads.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.

ASML Holding (ASML:NAS) and Nokia (NOK:NYS) Downgraded

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com



I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/toppicks.aspx.

Downgraded Stocks on NYSE, NASDAQ, AMEX, TSE, and TSX

Today we are looking at companies whose share price has been downgraded by at least one analyst in the last few days.

Why Do Companies Get Downgraded?

Companies can get downgraded for a number of reasons but primarily due to reduced future earnings potential due to loss of contracts, faultering product lines, increasing costs relative to revenue or financial risk.

In the list below you can see the number of analysts we have in the StockCalc database along with the number of buy-hold-sell on the company.

Today’s Data on NYSE, NASDAQ, AMEX, TSE, and TSX

Below we have today’s data for companies listed on all of the New York Stock Exchange, NASDAQ Stock Exchange, American Stock Exchange, Toronto Stock Exchange, and TSX Venture Exchange.

New York Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
NOK Nokia Oyj 1 0 4 0 0 0 3.4000 3.6667 Hold
PANW Palo Alto Networks Inc 8 0 3 0 1 0 4.1667 4.2308 Outperform
MSI Motorola Solutions Inc 5 1 0 0 0 0 4.8333 4.8571 Buy
VET Vermilion Energy Inc 6 4 3 0 0 0 4.2308 4.2727 Outperform
HR Healthcare Realty Trust Inc 1 0 1 0 0 0 4.0000 5.0000 Outperform
TEP Tallgrass Energy Partners LP 0 1 2 0 0 0 3.3333 4.0000 Hold
KRO Kronos Worldwide Inc 0 0 1 0 0 0 3.0000 5.0000 Hold
MRT MedEquities Realty Trust Inc 1 0 1 0 0 0 4.0000 5.0000 Outperform
SAR Saratoga Investment Corp 0 0 1 0 0 0 3.0000 5.0000 Hold
Toronto Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
VET Vermilion Energy Inc 6 4 3 0 0 0 4.2308 4.2727 Outperform
ORL Orocobre Ltd 4 0 1 0 0 0 4.6000 4.6667 Buy
PRU Perseus Mining Ltd 2 0 1 0 0 0 4.3333 4.5000 Outperform
TSX Venture Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
MCR Macro Enterprises Inc 1 2 0 0 0 0 4.3333 4.5000 Outperform
American Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
TEUM Pareteum Corp 1 1 0 0 0 0 4.5000 5.0000 Outperform
NASDAQ
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
CSCO Cisco Systems Inc 6 0 1 1 0 0 4.3750 4.4444 Outperform
ASML ASML Holding NV 2 0 3 1 0 0 3.5000 3.7143 Hold
ERIC Telefonaktiebolaget L M Ericsson 0 0 4 0 1 0 2.6000 3.0000 Hold
IART Integra Lifesciences Holdings Corp 2 0 3 0 0 0 3.8000 4.0000 Outperform
FEYE FireEye Inc 3 0 5 0 0 0 3.7500 3.8571 Outperform

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

ASML:NAS ASML Holding

http://www.asml.com
ASML Holding has 20265 employees and is headquartered in Netherlands.
ASML Holding NV is a part of the semiconductor industry. Its products include memory chip and logic chip, TWINSCAN systems, equipped with i-line, KrF and ArF light sources.

NOK:NYS Nokia

http://www.nokia.com
Nokia has 101731 employees and is headquartered in Finland.
Nokia Oyj is a telecommunication company. It develops network equipment to transmit data over wireless, copper, optical fiber, and microwave mediums. Its products are used by the world’s largest telecommunication service providers.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.

GMP Capital (GMP:TSE) and TearLab (TLB.DL:TSE) Trading at Less than Cash Value

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com



I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.

Trading at Less than Cash Value

Today we are looking at companies trading at less than cash value meaning companies whose current share price is less than the cash per share on the balance sheet. We also show the value of cash net debt per share to show how much cash per share would be left if the debt was paid off.

What this Means…

Companies can have more cash per share than the actual share price for a number of reasons including they just raised capital, are in industries that experience high burn rates and will eat through the cash quickly or if there is a lot of uncertainty about the future of the company. Companies earning a positive net income will have a P/E greater than 0 and are worth exploring in more detail.

Today’s Data on TSE

Today’s data is for companies listed on the Toronto Stock Exchange.

Symbol Name Close Price Shares Outstanding P/E P/B Cash per Share Net Cash per Share
TRZ Transat A.T. Inc 8.420000 37384003 1.9491 0.5581 20.04 13.78
GMP GMP Capital Inc 2.900000 78176271 None 1.2485 7.14 6.54
ARZ Aralez Pharmaceuticals Inc 0.500000 67194277 None 1.8573 0.65 -3.43
CXR Concordia International Corp 0.355000 51283800 None None 6.70 -65.51
KRN Karnalyte Resources Inc 0.400000 28116000 None 0.6597 0.40 0.89
TLB.DL TearLab Corp 0.330000 10216998 None None 0.73 -2.15
LRT.UN Lanesborough Real Estate Investment Trust 0.010000 20557320 None None 0.06 -11.72
MNT Royal Canadian Mint 17.870000 4000 None None 23651.75 11260.75
MNS Royal Canadian Mint 12.750000 4000 None None 23651.75 11260.75

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

GMP:TSE GMP Capital

http://www.gmpcapital.com
GMP Capital has 300 employees and is headquartered in Canada.
GMP Capital Inc is an investment dealer located in Canada. It provides diversified financial services such as investment banking, institutional sales, trading and research services to corporate clients and institutional investors.

TLB.DL:TSE TearLab

http://www.tearlab.com
TearLab has 42 employees and is headquartered in United States.
TearLab Corp is an in-vitro diagnostic company. The Company commercialized a proprietary tear testing platform, the TearLab Osmolarity System that enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.

CNOOC (CNU:TSE) and Brookfield Asset Mgmt (BAM.A:TSE) Upgraded

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com



I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/toppicks.aspx.

Upgraded Stocks on NYSE, NASDAQ, AMEX, TSE, and TSX

Today we are looking at companies whose share price has been upgraded by at least one analyst in the last few days.

Why Do Companies Get Upgraded?

Companies can get upgraded for a number of reasons, but primarily due to improved future earnings potential due to new contracts, new products, cost savings or restructuring.

In the list below you can see the number of analysts we have in the StockCalc database along with the number of buy-hold-sell on the company.

Today’s Data on NYSE, NASDAQ, AMEX, TSE, and TSX

Below we have today’s data for companies listed on all of the New York Stock Exchange, NASDAQ Stock Exchange, American Stock Exchange, Toronto Stock Exchange, and TSX Venture Exchange.

New York Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
CEO CNOOC Ltd 3 0 1 0 0 0 4.5000 4.3333 Outperform
BAM Brookfield Asset Management Inc 5 3 1 0 0 0 4.4444 4.3750 Outperform
SPOT Spotify Technology SA 4 0 1 1 0 0 4.1667 4.0000 Outperform
CP Canadian Pacific Railway Ltd 10 6 4 0 0 0 4.3000 4.2105 Outperform
AEM Agnico Eagle Mines Ltd 5 4 6 0 0 0 3.9333 3.8000 Outperform
PE Parsley Energy Inc 5 0 0 0 0 0 5.0000 4.6000 Buy
PRT PermRock Royalty Trust 1 0 0 0 0 0 5.0000 0.0000 Buy
Toronto Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
CNU CNOOC Ltd 3 0 1 0 0 0 4.5000 4.3333 Outperform
BAM.A Brookfield Asset Management Inc 5 3 1 0 0 0 4.4444 4.3750 Outperform
CP Canadian Pacific Railway Ltd 10 6 4 0 0 0 4.3000 4.2105 Outperform
AEM Agnico Eagle Mines Ltd 5 4 6 0 0 0 3.9333 3.8000 Outperform
BPY.UN Brookfield Property Partners LP 3 2 1 0 0 0 4.3333 4.2000 Outperform
CIGI Colliers International Group Inc 2 2 0 0 0 0 4.5000 4.3333 Outperform
SPE Spartan Energy Corp 1 2 3 0 2 0 3.0000 2.8182 Hold
TSX Venture Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
STC Sangoma Technologies Corp 2 1 0 0 0 0 4.6667 4.5000 Buy
NASDAQ
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
CHKP Check Point Software Technologies Ltd 4 0 7 0 0 0 3.7273 3.5000 Outperform
FFIV F5 Networks Inc 2 0 2 1 1 0 3.1667 3.1429 Hold
CDK CDK Global Inc 3 0 0 0 0 0 5.0000 4.3333 Buy
BPY Brookfield Property Partners LP 3 2 1 0 0 0 4.3333 4.2000 Outperform
CIGI Colliers International Group Inc 2 2 0 0 0 0 4.5000 4.3333 Outperform
ACIA Acacia Communications Inc 3 0 1 0 0 0 4.5000 4.3333 Outperform
ROAD Construction Partners Inc 1 0 0 0 0 0 5.0000 0.0000 Buy

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

CNU:TSE CNOOC

http://www.cnoocltd.com
CNOOC has 19030 employees and is headquartered in Hong Kong.
CNOOC Ltd is an oil and gas company. It is engaged in the exploration, development, production and sale of crude oil, natural gas and other petroleum products.

BAM.A:TSE Brookfield Asset Mgmt

http://www.brookfield.com
Brookfield Asset Mgmt has 80750 employees and is headquartered in Canada.
Brookfield Asset Management Inc is an alternative asset management company focused on property, renewable energy, infrastructure and private equity.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.

PetMed Express (PETS:NAS) Fundamental Valuation Report


This Report was generated using the tools available on StockCalc.com. Patchell Brook Equity Analytics Inc. emphasizes that the user assumes all risks associated with the use of this report or the Stockcalc website including, but not limited to, all terms and conditions mentioned in the legal disclaimer.
To access all of the tools on Stockcalc, including more detailed valuation reports and the models used to generate these valuations, please subscribe for a free 30 day trial of Stockcalc here.

PetMed Express $37.51 (USD) Close Price as of 29/05/2018

Based on the analysis conducted in this report, PetMed Express, (PETS:NAS) is found to be  Fairly valued to slightly Overvalued.

Company PetMed Express
Symbol:Exchange PETS:NAS
Industry Consumer Defensive:Pharmaceutical Retailers
Close Price/Date $37.51 (USD) 29/05/2018
Weighted Average Valuation $37.00 (USD)
Summary PETS:NAS is found to be  Fairly valued to slightly Overvalued by 1.4% using the 2 valuation models shown below.
Valuation Models Used Analyst Consensus: $45.00 (USD)
(in order of importance) Adjusted Book Value: $25.00 (USD)
Valuation Methods Analysis This company is:
Cash Flow Basis: Overvalued on a Cash Flow Valuation basis
Comparable Company Basis: Overvalued on a Comparable Valuation basis
Asset Basis: Overvalued on an Asset Valuation basis

Valuation Details

PetMed Express Valuations

Summary chart

 We have up to 6 valuation points for each company. Details are at the bottom of the report.

Discounted Cash Flow and Sensitivity Analysis for PETS:NAS

Using a discounted cash flow model we generated an intrinsic value of $26.94 (USD) for PETS:NAS

Sensitivity Analysis

(showing how changes in the input variables impact the DCF calculation)

PETS:NAS Current Values Valuation If Dropped * Valuation If Raised *
Calculated Value: $26.94 1% 5% 1% 5%
WACC (or Ke) 9.09 $32.30 $23.09
Terminal Growth Rate 3.00 $23.52 $31.69
Tax Rate 0.37 $29.06 $24.82
Cash Flow 62,830,000 $25.51 $28.37
Capital Expenditures -6,464,600 $26.79 $27.09
Long Term Debt 0 $26.94 $26.94

* Changes are absolute: ex WACC from 8% to 7%

Comparables Model

Using similar companies and price based ratios we generated a valuation of $8.34 (USD) for PETS:NAS. We also generated a valuation of $45.83 (USD) using other metrics and comparables.
The comparable companies were Rite Aid (RAD:NYS)

Company PETS:NAS End Date Value
Earnings/Share $1.82 (USD)
Book Value/Share $5.34 (USD)
Sales/Share $13.19 (USD)
Cash Flow/Share $2.48 (USD)
EBITDA/Share $0.00 (USD)
Price Based on Comps Adjustment Factor (%)
$0.00 (USD) -18.9
$5.84 (USD) 31.2
$1.06 (USD) 53.9
$16.04 (USD) -1.9
$0.00 (USD) -1.0
PETS:NAS Ratios Used Average Values RAD:NYS
22.06 PE Ratio 0.00 0.00
7.03 PB Ratio 1.09 1.09
2.84 PS Ratio 0.08 0.08
15.11 PCF Ratio 6.46 6.46
13.32 EV to EBITDA 8.61 8.61

Multiples

Using a multiples approach we generated a valuation of  $28.21 (USD) for PETS:NAS

Company PETS:NAS End Date Value
Earnings/Share $1.82 (USD)
Book Value/Share $5.34 (USD)
Sales/Share $13.19 (USD)
Cash Flow/Share $2.48 (USD)
EBITDA/Share $1.90 (USD)
Price Based on Comps Adjustment Factor
$35.38 (USD) 0
$25.29 (USD) 0
$21.91 (USD) 0
$38.56 (USD) 0
$19.91 (USD) 0
Ratios Ratio Average
PE Ratio 19.44
PB Ratio 4.74
PS Ratio 1.66
PCF Ratio 15.53
EV to EBITDA 10.47

Adjusted Book Value versus Historical Price to Book

The average the Price to Book ratio for  PETS:NAS for the last 10 years was  4.67

We ran the Adjusted Book Value for  PETS:NAS and generated a book value of  $5.36 (USD)
By multiplying these we get an adjusted valuation of  $25.00 (USD)

Analyst Data

In the Stockcalc database there are 2 analysts that provide a valuation for PETS:NAS. The 2 analysts have a concensus valuation for PETS:NAS for 2019 of $45.00 (USD).

PETS:NAS PetMed Express

Analyst Recommendation
Buy Hold Sell Rating
(of 5)
Guidance As Of
1 0 1 3.0000 Hold 2018-5-28

Current Price: not available

Analyst Consensus
USD Millions 2018 2019 2020
Mean EPS 1.82 2.22 2.46
# EPS Analysts 1 2 2
Mean Revenue 273.80 293.00 305.30
# Revenue Analysts 1 1 1
Mean Target Price 45.00
Mean Cash Flow 2.66 2.84 2.98
Mean EBITDA 54.30 58.00 61.00
Mean Net Income 37.30 43.90 46.20
Mean Debt Outstanding -77.90 -118.70 -118.70
Mean Tax Rate
Mean Growth Rate
Mean Capital Expenditure

Company Overview (PETS:NAS USD)

Price 37.51
Range 37.04 – 38.09
52 week 33.15 – 53.24
Open 37.82
Vol / Avg. 324046/228122
Mkt cap 772.74M
P/E 22.06
Div/yield 1.00/0.02
EPS 1.17
Shares 20.6M
Beta 0.71
Summary chart

Detailed Company Description

PetMed Express Inc is a nationwide pet pharmacy. The Company markets prescription and non-prescription pet medications and other health products for dogs, cats, and horses direct to the consumer.

Explanation of Valuation Models

We have up to 6 valuation points for each company in the database.

The Discounted Cash Flow (DCF) valuation is a cash flow model where cash flow projections are discounted back to the present to calculate value per share. DCF is a common valuation technique especially for companies undergoing irregular cash flows such as resource companies (mining, forestry, oil and gas) going though price cycles or smaller companies about to generate cash flow (junior exploration companies, junior pharma, technology firms…).

The Price Comparables valuation is the result of valuing the company we are looking at on the basis of ratios from selected comparable companies: Price to Earnings, Price to Book, Price to Sales, Price to Cash Flow, Enterprise Value (EV) to EBITDA. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

We have included the Other Comparables as a way to value companies that cannot be valued using Earnings based ratios. This technique is very useful for companies still experiencing negative cash flows such as mining exploration firms. We use Cash/Share, Book Value/Share, MarketCap, 1 Year Return, NetPPE as the ratios here. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

Multiples are similar to Price comparables where we look at current or historic ratios for the company in question to assess what it should be worth today based on those historic ratios. We use the same 5 ratios as in the price comparables and value the company with its historic averages.

With Adjusted Book Value (ABV) we calculate the book value per share for the company based on its balance sheet and multiply that book value per share by its historical price to book ratio to calculate a value per share.

If we have Analyst coverage for the company we use the consensus target price here.

Notice to User


The contents of this report and the Stockcalc website are provided on an ‘‘as is’’ or ‘‘as available’’ basis with all faults and may not be current in all cases. The information in this report or on the website is subject to continuous change and Patchell Brook Equity Analytics Inc. assumes no responsibility to update or amend such information or that the information will be current. Patchell Brook Equity Analytics Inc. does not claim that all information, calculations or opinions presented in this report or on its website are true, reliable, or complete. Accordingly, you should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment or other decision. Any information, data, opinions, calculations or recommendations provided by third parties through links to other websites or otherwise made available through this report or website are solely those of the third party and not of Patchell Brook Equity Analytics Inc. Please refer to the Terms of Use on www.stockcalc.com for further information.
To access all of the tools on Stockcalc, including more detailed valuation reports and the models used to generate these valuations, please subscribe for a free 30 day trial of Stockcalc here.

Mimecast (MIME:NAS) Fundamental Valuation Report


This Report was generated using the tools available on StockCalc.com. Patchell Brook Equity Analytics Inc. emphasizes that the user assumes all risks associated with the use of this report or the Stockcalc website including, but not limited to, all terms and conditions mentioned in the legal disclaimer.
To access all of the tools on Stockcalc, including more detailed valuation reports and the models used to generate these valuations, please subscribe for a free 30 day trial of Stockcalc here.

Mimecast $43.99 (USD) Close Price as of 29/05/2018

Based on the analysis conducted in this report, Mimecast, (MIME:NAS) is found to be  Overvalued.

Company Mimecast
Symbol:Exchange MIME:NAS
Industry Technology:Software-Infrastructure
Close Price/Date $43.99 (USD) 29/05/2018
Weighted Average Valuation $37.92 (USD)
Summary MIME:NAS is found to be  Overvalued by 13.8% using the 3 valuation models shown below.
Valuation Models Used Analyst Consensus: $47.00 (USD)
(in order of importance) Comparables: $29.02 (USD)
Adjusted Book Value: $28.49 (USD)
Valuation Methods Analysis This company is:
Cash Flow Basis: Overvalued on a Cash Flow Valuation basis
Comparable Company Basis: Overvalued on a Comparable Valuation basis
Asset Basis: Overvalued on an Asset Valuation basis

Valuation Details

Mimecast Valuations

Summary chart

 We have up to 6 valuation points for each company. Details are at the bottom of the report.

Discounted Cash Flow and Sensitivity Analysis for MIME:NAS

Using a discounted cash flow model we generated an intrinsic value of $5.43 (USD) for MIME:NAS

Sensitivity Analysis

(showing how changes in the input variables impact the DCF calculation)

MIME:NAS Current Values Valuation If Dropped * Valuation If Raised *
Calculated Value: $5.43 1% 5% 1% 5%
WACC (or Ke) 12.42 $6.13 $4.87
Terminal Growth Rate 3.00 $4.98 $6.00
Tax Rate 0.40 $5.81 $5.05
Cash Flow 57,832,435 $5.15 $5.71
Capital Expenditures -15,799,000 $5.36 $5.51
Long Term Debt 3,932,000 $5.44 $5.43

* Changes are absolute: ex WACC from 8% to 7%

Comparables Model

Using similar companies and price based ratios we generated a valuation of $36.79 (USD) for MIME:NAS. We also generated a valuation of $29.02 (USD) using other metrics and comparables.
The comparable companies were Cotiviti Holdings (COTV:NYS), CyberArk Software (CYBR:NAS), Q2 Holdings (QTWO:NYS) and Varonis Systems (VRNS:NAS)

Company MIME:NAS End Date Value
Cash/Share $0.00 (USD)
Book Value/Share $1.64 (USD)
MarketCap 2,593,194,839
1 Year Return 0.632
NetPPE 0
Price Based on Comps Adjustment Factor (%)
$0.00 (USD) 0
$13.98 (USD) 0
$34.81 (USD) 0
$38.27 (USD) 0
$0.00 (USD) 0
Ratios Used Average Values COTV:NYS CYBR:NAS QTWO:NYS VRNS:NAS
Cash / Share 2.41 1.74 4.45 1.40 2.05
Book Value / Share 6.70 11.23 9.84 2.54 3.19
Market Cap 2,001,863,400 3,245,320,745 1,613,726,707 1,770,135,931 1,378,270,218
1 Year Return 0.42 -0.11 0.22 0.45 1.11
Net PPE 33,252,500 77,340,000 9,230,000 34,544,000 11,896,000

Multiples

Using a multiples approach we generated a valuation of  $25.38 (USD) for MIME:NAS

Company MIME:NAS End Date Value
Earnings/Share ($0.25) (USD)
Book Value/Share $1.64 (USD)
Sales/Share $4.26 (USD)
Cash Flow/Share $0.73 (USD)
EBITDA/Share $0.16 (USD)
Price Based on Comps Adjustment Factor
$0.00 (USD) 0
$27.02 (USD) 0
$28.53 (USD) 0
$28.73 (USD) 0
$17.24 (USD) 0
Ratios Ratio Average
PE Ratio 641.83
PB Ratio 16.52
PS Ratio 6.70
PCF Ratio 39.12
EV to EBITDA 110.81

Adjusted Book Value versus Historical Price to Book

The average the Price to Book ratio for  MIME:NAS for the last 3 years was  16.52

We ran the Adjusted Book Value for  MIME:NAS and generated a book value of  $1.73 (USD)
By multiplying these we get an adjusted valuation of  $28.49 (USD)

Analyst Data

In the Stockcalc database there are 3 analysts that provide a valuation for MIME:NAS. The 3 analysts have a concensus valuation for MIME:NAS for 2019 of $47.00 (USD).

MIME:NAS Mimecast

Analyst Recommendation
Buy Hold Sell Rating
(of 5)
Guidance As Of
3 0 0 5.0000 Buy 2018-5-28

Current Price: not available

Analyst Consensus
USD Millions 2018 2019 2020
Mean EPS 0.02 0.19 0.32
# EPS Analysts 3 3 3
Mean Revenue 261.90 334.30 395.30
# Revenue Analysts 3 3 3
Mean Target Price 47.00
Mean Cash Flow 0.74 1.06 1.28
Mean EBITDA 37.20 53.20
Mean Net Income -1.00 17.70 24.70
Mean Debt Outstanding
Mean Tax Rate 122.30 37.60 31.70
Mean Growth Rate 25.00
Mean Capital Expenditure 32.30 32.40 36.80

Company Overview (MIME:NAS USD)

Price 0.00
Range 0.00 – 0.00
52 week 0.00 – 0.00
Open 0.00
Vol / Avg. 0/0
Mkt cap 0
P/E 0.00
Div/yield 0.00/0.00
EPS 0.00
Shares 0
Beta 0.00
Summary chart

Detailed Company Description

Mimecast Limited is a software solutions provider. Its key business involves provision of a software platform to evade internet security issues such as malware and spam.

Explanation of Valuation Models

We have up to 6 valuation points for each company in the database.

The Discounted Cash Flow (DCF) valuation is a cash flow model where cash flow projections are discounted back to the present to calculate value per share. DCF is a common valuation technique especially for companies undergoing irregular cash flows such as resource companies (mining, forestry, oil and gas) going though price cycles or smaller companies about to generate cash flow (junior exploration companies, junior pharma, technology firms…).

The Price Comparables valuation is the result of valuing the company we are looking at on the basis of ratios from selected comparable companies: Price to Earnings, Price to Book, Price to Sales, Price to Cash Flow, Enterprise Value (EV) to EBITDA. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

We have included the Other Comparables as a way to value companies that cannot be valued using Earnings based ratios. This technique is very useful for companies still experiencing negative cash flows such as mining exploration firms. We use Cash/Share, Book Value/Share, MarketCap, 1 Year Return, NetPPE as the ratios here. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

Multiples are similar to Price comparables where we look at current or historic ratios for the company in question to assess what it should be worth today based on those historic ratios. We use the same 5 ratios as in the price comparables and value the company with its historic averages.

With Adjusted Book Value (ABV) we calculate the book value per share for the company based on its balance sheet and multiply that book value per share by its historical price to book ratio to calculate a value per share.

If we have Analyst coverage for the company we use the consensus target price here.

Notice to User


The contents of this report and the Stockcalc website are provided on an ‘‘as is’’ or ‘‘as available’’ basis with all faults and may not be current in all cases. The information in this report or on the website is subject to continuous change and Patchell Brook Equity Analytics Inc. assumes no responsibility to update or amend such information or that the information will be current. Patchell Brook Equity Analytics Inc. does not claim that all information, calculations or opinions presented in this report or on its website are true, reliable, or complete. Accordingly, you should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment or other decision. Any information, data, opinions, calculations or recommendations provided by third parties through links to other websites or otherwise made available through this report or website are solely those of the third party and not of Patchell Brook Equity Analytics Inc. Please refer to the Terms of Use on www.stockcalc.com for further information.
To access all of the tools on Stockcalc, including more detailed valuation reports and the models used to generate these valuations, please subscribe for a free 30 day trial of Stockcalc here.

DXC Technology (DXC:NYS) Fundamental Valuation Report


This Report was generated using the tools available on StockCalc.com. Patchell Brook Equity Analytics Inc. emphasizes that the user assumes all risks associated with the use of this report or the Stockcalc website including, but not limited to, all terms and conditions mentioned in the legal disclaimer.
To access all of the tools on Stockcalc, including more detailed valuation reports and the models used to generate these valuations, please subscribe for a free 30 day trial of Stockcalc here.

DXC Technology $89.99 (USD) Close Price as of 29/05/2018

Based on the analysis conducted in this report, DXC Technology, (DXC:NYS) is found to be  Undervalued.

Company DXC Technology
Symbol:Exchange DXC:NYS
Industry Technology:Information Technology Services
Close Price/Date $89.99 (USD) 29/05/2018
Weighted Average Valuation $116.93 (USD)
Summary DXC:NYS is found to be  Undervalued by 29.9% using the 3 valuation models shown below.
Valuation Models Used Analyst Consensus: $109.25 (USD)
(in order of importance) Comparables: $124.97 (USD)
Adjusted Book Value: $123.89 (USD)
Valuation Methods Analysis This company is:
Cash Flow Basis: Undervalued on a Cash Flow Valuation basis
Comparable Company Basis: Undervalued on a Comparable Valuation basis
Asset Basis: Undervalued on an Asset Valuation basis

Valuation Details

DXC Technology Valuations

Summary chart

 We have up to 6 valuation points for each company. Details are at the bottom of the report.

Discounted Cash Flow and Sensitivity Analysis for DXC:NYS

Using a discounted cash flow model we generated an intrinsic value of $145.59 (USD) for DXC:NYS

Sensitivity Analysis

(showing how changes in the input variables impact the DCF calculation)

DXC:NYS Current Values Valuation If Dropped * Valuation If Raised *
Calculated Value: $145.59 1% 5% 1% 5%
WACC (or Ke) 7.72 $185.39 $119.04
Terminal Growth Rate 2.70 $121.44 $181.76
Tax Rate 0.40 $159.89 $131.30
Cash Flow 4,726,356,700 $136.53 $154.65
Capital Expenditures -345,600,000 $144.91 $146.28
Long Term Debt 3,300,000,000 $146.17 $145.01

* Changes are absolute: ex WACC from 8% to 7%

Comparables Model

Using similar companies and price based ratios we generated a valuation of $118.09 (USD) for DXC:NYS. We also generated a valuation of $124.97 (USD) using other metrics and comparables.
The comparable companies were CDW (CDW:NAS), Cognizant Tech Solns (CTSH:NAS), Gartner (IT:NYS), Leidos Holdings (LDOS:NYS) and Xerox (XRX:NYS)

Company DXC:NYS End Date Value
Cash/Share $0.00 (USD)
Book Value/Share $44.93 (USD)
MarketCap 25,709,050,971
1 Year Return 0.144
NetPPE 0
Price Based on Comps Adjustment Factor (%)
$0.00 (USD) 0
$229.19 (USD) 0
$56.85 (USD) 0
$88.89 (USD) 0
$0.00 (USD) 0
Ratios Used Average Values CDW:NAS CTSH:NAS IT:NYS LDOS:NYS XRX:NYS
Cash / Share 3.54 0.91 3.24 6.02 2.55 5.01
Book Value / Share 14.66 5.72 18.01 8.15 21.66 19.77
Market Cap 16,472,123,789 10,537,437,181 43,688,522,527 11,176,372,987 9,237,389,302 7,720,896,948
1 Year Return 0.13 0.36 0.12 0.11 0.09 -0.02
Net PPE 604,321,400 161,100,000 1,324,000,000 221,507,000 232,000,000 1,083,000,000

Multiples

Using a multiples approach we generated a valuation of  $174.98 (USD) for DXC:NYS

Company DXC:NYS End Date Value
Earnings/Share $6.04 (USD)
Book Value/Share $44.93 (USD)
Sales/Share $80.70 (USD)
Cash Flow/Share $10.87 (USD)
EBITDA/Share $2.07 (USD)
Price Based on Comps Adjustment Factor
$562.49 (USD) 0
$126.69 (USD) 0
$77.17 (USD) 0
$86.21 (USD) 0
$22.35 (USD) 0
Ratios Ratio Average
PE Ratio 93.13
PB Ratio 2.82
PS Ratio 0.96
PCF Ratio 7.93
EV to EBITDA 10.78

Adjusted Book Value versus Historical Price to Book

The average the Price to Book ratio for  DXC:NYS for the last 10 years was  2.73

We ran the Adjusted Book Value for  DXC:NYS and generated a book value of  $45.33 (USD)
By multiplying these we get an adjusted valuation of  $123.89 (USD)

Analyst Data

In the Stockcalc database there are 4 analysts that provide a valuation for DXC:NYS. The 4 analysts have a concensus valuation for DXC:NYS for 2019 of $109.25 (USD).

DXC:NYS DXC Technology

Analyst Recommendation
Buy Hold Sell Rating
(of 5)
Guidance As Of
2 2 0 3.6000 Outperform 2018-5-28

Current Price: not available

Analyst Consensus
USD Millions 2018 2019 2020
Mean EPS 7.90 8.57 9.45
# EPS Analysts 4 4 2
Mean Revenue 24,556.00 21,958.80 22,368.40
# Revenue Analysts 2 2 2
Mean Target Price 109.25
Mean Cash Flow 11.18 12.10 13.63
Mean EBITDA 3,849.00 4,261.90 4,602.10
Mean Net Income 2,316.50 2,291.60 2,502.00
Mean Debt Outstanding
Mean Tax Rate 27.40 25.00 25.00
Mean Growth Rate 4.34
Mean Capital Expenditure 224.00 330.20 560.20

Company Overview (DXC:NYS USD)

Price 89.99
Range 88.14 – 93.37
52 week 74.10 – 107.31
Open 92.89
Vol / Avg. 5.92M/1.26M
Mkt cap 25.7B
P/E 29.41
Div/yield 0.76/0.01
EPS -0.88
Shares 285.55M
Beta 1.15
Summary chart

Detailed Company Description

DXC Technology Co is an independent, end-to-end IT services company. It provides information technology and consulting services and solutions to enterprise clients.

Explanation of Valuation Models

We have up to 6 valuation points for each company in the database.

The Discounted Cash Flow (DCF) valuation is a cash flow model where cash flow projections are discounted back to the present to calculate value per share. DCF is a common valuation technique especially for companies undergoing irregular cash flows such as resource companies (mining, forestry, oil and gas) going though price cycles or smaller companies about to generate cash flow (junior exploration companies, junior pharma, technology firms…).

The Price Comparables valuation is the result of valuing the company we are looking at on the basis of ratios from selected comparable companies: Price to Earnings, Price to Book, Price to Sales, Price to Cash Flow, Enterprise Value (EV) to EBITDA. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

We have included the Other Comparables as a way to value companies that cannot be valued using Earnings based ratios. This technique is very useful for companies still experiencing negative cash flows such as mining exploration firms. We use Cash/Share, Book Value/Share, MarketCap, 1 Year Return, NetPPE as the ratios here. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

Multiples are similar to Price comparables where we look at current or historic ratios for the company in question to assess what it should be worth today based on those historic ratios. We use the same 5 ratios as in the price comparables and value the company with its historic averages.

With Adjusted Book Value (ABV) we calculate the book value per share for the company based on its balance sheet and multiply that book value per share by its historical price to book ratio to calculate a value per share.

If we have Analyst coverage for the company we use the consensus target price here.

Notice to User


The contents of this report and the Stockcalc website are provided on an ‘‘as is’’ or ‘‘as available’’ basis with all faults and may not be current in all cases. The information in this report or on the website is subject to continuous change and Patchell Brook Equity Analytics Inc. assumes no responsibility to update or amend such information or that the information will be current. Patchell Brook Equity Analytics Inc. does not claim that all information, calculations or opinions presented in this report or on its website are true, reliable, or complete. Accordingly, you should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment or other decision. Any information, data, opinions, calculations or recommendations provided by third parties through links to other websites or otherwise made available through this report or website are solely those of the third party and not of Patchell Brook Equity Analytics Inc. Please refer to the Terms of Use on www.stockcalc.com for further information.
To access all of the tools on Stockcalc, including more detailed valuation reports and the models used to generate these valuations, please subscribe for a free 30 day trial of Stockcalc here.